Print   

                                       NextGen Group plc ('NextGen' or the 'Company')

Placing to raise £639,000

NextGen is pleased to announce that it has placed 426,000,000 ordinary shares of 0.1 pence each (the 'Placing Shares') with two existing shareholders of the Company (the 'Placing'). The Placing Shares are to be issued at 0.15 pence per share to raise £639,000 before expenses, in order to provide development funding and general working capital for the Company, which the Directors believe will be sufficient for its current requirements. 

In addition, for every 2 Placing Shares issued pursuant to the Placing, the Company will grant a warrant over 1 ordinary share of 0.1 pence each (the 'Ordinary Shares') with an exercise price of 0.15 pence per share. Accordingly, warrants over 213,000,000 Ordinary Shares will be granted pursuant to the Placing. The Warrants shall be exercisable for 3 years from the date of grant.

Following the Placing, the Company will have in issue 2,546,978,644 Ordinary Shares. The Placing Shares will represent 16.73 per cent of the enlarged issued share capital immediately following the issue of the Placing Shares and will rank pari passu in all respects with the existing Ordinary Shares.

The two subscribing shareholders are Perfekt Beteiligungsmanagement GmbH ('Perfekt) and Family Trust Select - FIS - Teilfonds Zeus ('Zeus') and the details of the subscription are as follows:

	Number of Ordinary Shares held before Placing	Number of Placing Shares	Number of Warrants granted
Perfekt	279,770,806	12,000,000	6,000,000
Zeus	860,167,000	414,000,000	207,000,000

The shareholdings of Perfekt and Zeus following the Placing are as follows:

	Number of Ordinary Shares held	% of issued Ordinary Share Capital
Perfekt	291,770,806	11.46
Zeus	1,274,167,000	50.02

As the Company is no longer centrally managed and controlled in the UK, Channel Islands or Isle of Man, it is no longer subject to the City Code on Takeovers and Mergers ('City Code'). 

Accordingly the Placing is not subject to the City Code. Investors should be aware that they are not afforded the protections of the City Code.

Application has been made for the Placing Shares to be admitted to trading on the AIM market of the London Stock Exchange and admission of the shares is expected to be on 1 December 2008. The warrants will not be admitted to trading on AIM. The Placing Shares and any new Ordinary Shares to be issued upon exercise of the warrants will rank pari passu with the existing Ordinary Shares of the Company. 

For further details please contact:

 

Dr Michael Pisano

CEO, NextGen Group PLC        01480 410 850

Jonathan Wright/Nicola Marrin

Seymour Pierce Limited          020 7107 8000

Notes to Editors:

About NextGen Sciences

NextGen Group PLC (LSE:NGG) is a provider of expert systems, services and reagents focused on enabling enhanced access to and understanding of the role of proteins in diagnosis and drug discovery. The expert systems are built out of NextGen's understanding of biological sciences and combine robotics, advanced engineering and rules based software in systems that range from partial to fully automated. NextGen also uses its systems and instruments to provide fee-for-service products under the Brand Name contractexpressTM to the pharmaceutical and biotechnology industry as well as those in academic research. 

NextGen Group PLC floated on the AIM market in London in December 2005 raising £2.4 million in an oversubscribed offering which included strong institutional investor support from Germany as well as in the UK. Further details relating to NextGen Group PLC and its products can be found at www.nextgensciences.com

ENDIOEILFFVLILDFIT